Evidence map›Paper›PMID 18163512›Full record

ArticleArthritis and rheumatism2008

Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes.

Eleonora Olivotto, Rosa Maria Borzi, Roberta Vitellozzi, Stefania Pagani, Annalisa Facchini, Michela Battistelli, Marianna Penzo, Xiang Li, Flavio Flamigni, Jun Li and 3 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Suppressing Chondrocyte Hypertrophy to Build Better Cartilage.Bioengineering (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Runx2 plays a central role in Osteoarthritis development.Journal of orthopaedic translation · 2020
    Review
  13. NF-κB Signaling Regulates Physiological and Pathological Chondrogenesis.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Eleonora OlivottoIstituti Ortopedici Rizzoli, Bologna, Italy.
Rosa Maria Borzi
Roberta Vitellozzi
Stefania Pagani
Annalisa Facchini
Michela Battistelli
Marianna Penzo
Xiang Li
Flavio Flamigni
Jun Li
Elisabetta Falcieri
Andrea Facchini
Kenneth B Marcu
Istituto Ortopedico Rizzoli · ITBoehringer Ingelheim (United States) · USUniversity of Bologna · ITUniversity of Urbino · ITStony Brook University · USVita-Salute San Raffaele University · IT

Funding

Novel roles of IKK complex to program gene expressionR01GM066882 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI MARCU, KENNETH B · 2003 to 2006
$1.3M
NIGMS NIH HHS GM-066882NIGMS NIH HHS R01 GM066882
6 · The paper itself

Abstract

objectiveOsteoarthritic (OA) chondrocytes behave in an intrinsically deregulated manner, characterized by chronic loss of healthy cartilage and inappropriate differentiation to a hypertrophic-like state. IKKalpha and IKKbeta are essential kinases that activate NF-kappaB transcription factors, which in turn regulate cell differentiation and inflammation. This study was undertaken to investigate the differential roles of each IKK in chondrocyte differentiation and hypertrophy.

methodsExpression of IKKalpha or IKKbeta was ablated in primary human chondrocytes by retro-transduction of specific short-hairpin RNAs. Micromass cultures designed to reproduce chondrogenesis with progression to the terminal hypertrophic stage were established, and anabolism and remodeling of the extracellular matrix (ECM) were investigated in the micromasses using biochemical, immunohistochemical, and ultrastructural techniques. Cellular parameters of hypertrophy (i.e., proliferation, viability, and size) were also analyzed.

resultsThe processes of ECM remodeling and mineralization, both characteristic of terminally differentiated hypertrophic cells, were defective following the loss of IKKalpha or IKKbeta. Silencing of IKKbeta markedly enhanced accumulation of glycosaminoglycan in conjunction with increased SOX9 expression. Ablation of IKKalpha dramatically enhanced type II collagen deposition independent of SOX9 protein levels but in association with suppressed levels of runt-related transcription factor 2. Moreover, IKKalpha-deficient cells retained the phenotype of cells in a pre-hypertrophic-like state, as evidenced by the smaller size and faster proliferation of these cells prior to micromass seeding, along with the enhanced viability of their differentiated micromasses.

conclusionIKKalpha and IKKbeta exert differential roles in ECM remodeling and endochondral ossification, which are events characteristic of hypertrophic chondrocytes and also complicating factors often found in OA. Because the effects of IKKalpha were more profound and pleotrophic in nature, our observations suggest that exacerbated IKKalpha activity may be responsible, at least in part, for the characteristic abnormal phenotypes of OA chondrocytes.

Indexed as

Cell DifferentiationCells, CulturedCell SurvivalChondrocytesCollagen Type IICore Binding Factor Alpha 1 SubunitExtracellular MatrixGene SilencingHigh Mobility Group ProteinsHumansHypertrophyI-kappa B KinaseOsteoarthritisPhenotypeRNA, MessengerSOX9 Transcription FactorCHUK protein, humanCollagen Type IICore Binding Factor Alpha 1 SubunitHigh Mobility Group ProteinsI-kappa B KinaseIKBKB protein, humanRNA, MessengerRUNX2 protein, humanSOX9 protein, humanSOX9 Transcription FactorTranscription Factors

Identifiers

PMID18163512
PMCPMC2927097
OpenAlexW1971211678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.